CHINA PHARMA HOLDINGS, INC. Proceeds from (Repayments of) Related Party Debt
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Proceeds from (Repayments of) Related Party Debt of -$77.53 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2020-11-13
- CHINA PHARMA HOLDINGS, INC. proceeds from (repayments of) related party debt for the quarter ending 2020-09-30 was -$168.08K, a 880.83% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. proceeds from (repayments of) related party debt for the quarter ending 2019-12-31 was -$36.10K.
- CHINA PHARMA HOLDINGS, INC. proceeds from (repayments of) related party debt for the quarter ending 2019-09-30 was $21.53K.
- CHINA PHARMA HOLDINGS, INC. proceeds from (repayments of) related party debt for the quarter ending 2019-06-30 was -$111.69K.
- CHINA PHARMA HOLDINGS, INC. proceeds from (repayments of) related party debt for fiscal 2019 was -$245.83K.
- CHINA PHARMA HOLDINGS, INC. proceeds from (repayments of) related party debt for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CHINA PHARMA HOLDINGS, INC. proceeds from (repayments of) related party debt for fiscal 2012 was $493.00K.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$168.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$77.53K 10-Q · filed 2020-11-13 | ||
| 2020-06-30 | $90.55K 10-Q · filed 2020-08-13 | |||
| 2019-12-31 | -$36.10K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$14.58K derived: sum of 2 quarters · filed 2020-11-13 | -$126.27K derived: sum of 3 quarters · filed 2020-11-13 | -$245.83K 10-K · filed 2020-03-30 |
| 2019-09-30 | $21.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$90.17K derived: sum of 2 quarters · filed 2020-11-13 | -$209.73K 10-Q · filed 2020-11-13 | |
| 2019-06-30 | -$111.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$231.25K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | -$119.56K 10-Q · filed 2020-05-14 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $0.00 derived: sum of 2 quarters · filed 2014-03-20 | $0.00 10-K · filed 2014-03-20 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | ||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 | |||
| 2012-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $200.00K derived: sum of 2 quarters · filed 2014-03-20 | $493.00K 10-K · filed 2014-03-20 | |
| 2012-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $393.00K 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $293.00K 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |